MedPath

A study on increased blood sugar levels after use of Dexamethasone (Steroid) in Cancer Patients

Not Applicable
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2023/10/058185
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Newly diagnosed with Cancer, Non-diabetic

Patients prescribed with Dexamethasone (Study Cohort)

Patients not being prescribed with Dexamethasone (Reference Cohort)

Exclusion Criteria

Out-patients, Diabetic, Patients who already have a history with Dexamethasone

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of Dexamethasone induced hyperglycemia. <br/ ><br>Timepoint: 24th hour after administration of one dose of Dexamethasone.
Secondary Outcome Measures
NameTimeMethod
Factors affecting dexamethasone induced hyperglycemiaTimepoint: 24th hour after administration of one dose of Dexamethasone.
© Copyright 2025. All Rights Reserved by MedPath